Diagnosis of HIV infection in pregnancy: Data from a national cohort of pregnant women with HIV in Italy

Epidemiology and Infection

Volumn 134, Issue 5, 2006, Pages 1120-1127

  Floridia, M ^a   Ravizza, M ^b   Tamburrini, E ^c   Anzidei, G ^d   Tibaldi, C ^e   Maccabruni, A ^f   Guaraldi, G ^g   Alberico, S ^h   Vimercati, A ⁱ   Antoni, A Degli ^j   Ferrazzi, E ^k  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

^d NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^e UNIVERSITY OF TURIN   (Italy)

^f FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^g UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^h Policlinic Hospital   (Italy)

ⁱ UNIVERSITY OF BARI   (Italy)

^j UNIVERSITY HOSPITAL OF PARMA   (Italy)

^k UNIVERSITY OF MILAN   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; BLOOD TRANSFUSION; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC ERROR; DISEASE TRANSMISSION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; ITALY; MAJOR CLINICAL STUDY; MULTIDRUG RESISTANCE; MULTIVARIATE ANALYSIS; OBSERVATIONAL STUDY; PATIENT COUNSELING; PREGNANCY; PRENATAL CARE; PRIMIPARA; RACE DIFFERENCE; SEXUAL TRANSMISSION; SYMPTOM; VIRUS IDENTIFICATION;

ADULT; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; DIAGNOSTIC ERRORS; DISEASE TRANSMISSION, VERTICAL; FEMALE; HIV INFECTIONS; HUMANS; INFANT, NEWBORN; ITALY; LOGISTIC MODELS; POPULATION SURVEILLANCE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVALENCE; RISK FACTORS; STATISTICS, NONPARAMETRIC;

EID: 33646673736     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268806006066     Document Type: Article

References (16)

1. Cooper ER, et al. Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. Journal of Acquired Immune Deficiency Syndrome 2002; 29: 484-494.
2. Dorenbaum A, et al. Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: A randomized trial. Journal of the American Medical Association 2002; 288: 189-198.
3. Bucceri AM, et al. Combination antiretroviral therapy in 100 HIV-1-infected pregnant women. Human Reproduction 2002; 17: 436-441.
4. The International Perinatal HIV Group. The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1 - a meta-analysis of 15 prospective cohort studies. New England Journal of Medicine 1999; 340: 977-987.
5. Shapiro D, et al. Mother-to-child transmission rates according to antiretroviral therapy, mode of delivery, and viral load (PACTG 367) [Abstract 114]. 9th Conference on Retroviruses and Opportunistic Infections. 24-28 February 2002; Seattle, WA.
6. Newell ML, et al. Vertical transmission of HIV-1: Maternal immune status and obstetric factors. The European Collaborative Study. AIDS 1996; 10: 1675-1681.
7. Connor EM, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. New England Journal of Medicine 1994; 331: 1173-1180.
8. Chou R, et al. US Preventive Services Task Force. Screening for HIV: A review of the evidence for the U.S. Preventive Services Task Force. Annals of Internal Medicine 2005; 143: 55-73.
9. European Collaborative Study. Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy. Clinical Infectious Diseases 2005; 40: 458-465.
10. CDC. Prenatal HIV testing and antiretroviral prophylaxis at an urban hospital - Atlanta, Georgia, 1997-2000. Morbidity and Mortality Weekly Report 2004; 52: 1245-1248.
11. Coll O, et al. Pregnancy and HIV infection: A European consensus on management. AIDS 2002; 16 (Suppl. 2): S1-S18.
12. Public Health Service Task Force. Recommendations for use of antiretroviral drugs in pregnant HIV-1 infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States [online]. (http://aidsinfo.nih.gov/ContentFiles/ PerinatalGL.pdf). Accessed 19 December 2005.
13. European Collaborative Study. Pregnancy-related changes in the longer-term management of HIV-infected women in Europe. European Journal of Obstetrics and Gynecology and Reproductive Biology 2003; 111:3-8.
14. Sanders GD, et al. Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy. New England Journal of Medicine 2005; 352: 570-585.
15. Paltiel AD, et al. Expanded screening for HIV in the United States - an analysis of cost-effectiveness. New England Journal of Medicine 2005; 352: 586-595.
16. Zaric GS, et al. The cost effectiveness of voluntary prenatal and routine newborn HIV screening in the United States. Journal of Acquired Immune Deficiency Syndrome 2000; 25: 403-416.